Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide MMX in mild-to-moderate active ulcerative colitis
NCT00679432Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2008
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of budesonide in ulcerative colitis (UC), sponsored by Valeant Pharmaceuticals. Started Jun 2008; status: completed.
02
Drugs
budesonide
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00679432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679432.